Fig. 8From: ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysisANLN and UBE2T are potential prognostic biomarkers in breast cancer. ANLN and UBE2T were consistently associated with Th1 and Th2, shifting the Th1/Th2 balance to Th1 in Luminal-B breast cancer, which indicates a poor prognosis. Created with BioRender.comBack to article page